Melatonin as a potential therapeutic agent in psychiatric illness
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The aim of this review was to summarize the potential use of melatonin in the treatment of mental disorders, specifically bipolar disorders, depression, and schizophrenia. To date, melatonin has been most commonly used in psychiatry because of its hypnotic, rhythm resynchronizing, and antioxidant actions. Here, we examine other properties of the melatonin including its anti‐inflammatory, antinociceptive, anxiolytic, and drug detoxification actions as well as its protective effects against neural loss. The brain is an intricate sensory and motor organ which receives information from both the external and internal environments. It transduces information into complex chemical and electrical signals which are transmitted throughout the central nervous system (CNS) and the organism. The pathogenesis of mental disorders remains ambiguous and neuroinflammation has been proposed as a causative agent. We consider the potential contributions of melatonin as therapeutic agent in CNS and during neuroinflammation in mental disorders. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800 · cited 1×
“Etiologically, the disorder is multifactorial and involves multiple genetic variants (Walsh et al., 2008) and environmental influences (Shao and Vawter, 2008).”
Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · cited 3×
“, 2009), eliminating free radicals (Peyrot and Ducroig, 2008; Reiter, 2003, 2005a,b, 2007; Tan et al., 2007), intervening in lipid metabolism (Maldonado et al.”
Self-citationMelatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875 · cited 1×
“The neural pacemaker for this rhythm is SCN; they impose 24-h rhythm on both endocrine and autonomic function and determine the daily rhythmicity of organs and systems (Pandi-Perumal et al., 2006).”
Identification of a serotonin/glutamate receptor complex implicated in psychosis
González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803
Geddes, J. R., Burgess, S., Hawton, K., Jamison, K., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.217 · Cited by 661
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371 · cited 1×
“…rise in leukocyte adhesiveness/aggregation (Bruce, 2007; Leonard and Myint, 2009) and pro-inflammatory cytokine production in depressive patients (Myint et al., 2005; Leonard, 2007) may account for a rapid recruitment of T-cells from the blood compartment, causing a cellmediated inflammation and…”
Diem, S. J. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1240 · Cited by 326 · cited 1×
“5-HT transporters have recently been described in bone; this raises the possibility that medications which block 5-HT reuptake may influence Copyright # 2009 John Wiley & Sons, Ltd. bone metabolism (Diem et al., 2007).”
Srinivasan, V., Smits, M., Spence, W., Lowe, A. D., Kayumov, L., Pandi-Perumal, S. R., Parry, B., & Cardinali, D. P. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600571822 · Cited by 292
Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
Haney, E. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1246 · Cited by 286
Should Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277 · cited 2×
“…cardiovascular disease (atherosclerosis and myocardial infarction) (Vaccarino et al., 2007), metabolic syndrome (insulin resistance and obesity) (Mcintyre et al., 2007), immune dysfunction [increased pro-inflammatory cytokines (TNFa, IL-1, IL-6), decreased anti-inflammatory cytokines (IL-4 Hum.”
Cited by
Hardeland, R., Madrid, J. A., Tan, D., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00934.x · Cited by 448
Self-citationChronic dim light at night provokes reversible depression-like phenotype: possible role for TNF
Bedrosian, T. A., Weil, Z. M., & Nelson, R. J. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.96 · Cited by 112
Anderson, G., & Maes, M. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9307-9 · Cited by 105
“Melatonin is not only a hypnotic and circadian rhythm resynchronizing compound, it is also a strong antioxidant and antiinflammatory agent (Maldonado et al. 2009a, b).”
Cubero-Millán, I., Molina-Carballo, A., Machado-Casas, I., Fernández-López, L., Martínez-Serrano, S., Tortosa-Pinto, P., Ruiz-López, A., Luna-del-Castillo, J.-D.-D., Uberos, J., & Muñoz-Hoyos, A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150917115 · Cited by 19
“damage [53,54].”
Metadata
- Authors
- Maldonado, M. D., Reiter, R. J., & Pérez‐San‐Gregorio, M. A.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2009-06-23
- Volume
- 24
- Issue
- 5
- Pages
- 391-400
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2048348570
- Cited by
- 54
- References
- 18
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Melatonin as a potential therapeutic agent in psychiatric illness. https://app.cochat.ai/papers/10.1002/hup.1032
- The paper
- Maldonado, M. D., Reiter, R. J., & Pérez‐San‐Gregorio, M. A. (2009). Melatonin as a potential therapeutic agent in psychiatric illness. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.1032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.